Suchergebnisse - "Amiri, Mohammad Mehdi"

PubPharm (7)

1

A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2023

von Mohammadi, M. | Jeddi-Tehrani, M. | Golsaz-Shirazi, F. | +10

2

Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies

enthalten in: Cancer chemotherapy and pharmacology | 2022

von Hassani, D. | Jeddi-Tehrani, M. | Yousefi, P. | +6

3

Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models

enthalten in: Investigational new drugs | 2021

von Shiravi, F. | Mohammadi, M. | Golsaz-Shirazi, F. | +9

4

A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo

enthalten in: Frontiers in immunology | 2020

von Mohammadi, M. | Jeddi-Tehrani, M. | Golsaz-Shirazi, F. | +9

5

Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody

enthalten in: Iranian journal of immunology : IJI | 2019

von Amiri, M. | Bahadori, T. | Soltantoyeh, T. | +4

6

Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro

enthalten in: Iranian journal of immunology : IJI | 2017

von Hosseini Ghatar, R. | Soltantoyeh, T. | Bahadori, M. | +5

7

In vitro assessment of the effects of anti-HER2 monoclonal antibodies on proliferation of HER2-overexpressing breast cancer cells

enthalten in: Immunotherapy | 2014

von Tahmasebi, F. | Kazemi, T. | Amiri, M. | +6

1
[1]